RENEE BREITENBACH: Open Payments
NPI 1366704124 · STUART, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$857 in 46 payments from 9 companies in 2025. Trend: 2023 $681 · 2024 $1,164 · 2025 $857
Food & beverage: $857
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $383 |
| E.R. Squibb & Sons, L.L.C. | 4 | $109 |
| Otsuka America Pharmaceutical, Inc. | 4 | $98 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $76 |
| Vanda Pharmaceuticals Inc. | 3 | $62 |
| Axsome Therapeutics, Inc. | 2 | $51 |
| Lundbeck LLC | 2 | $37 |
| Teva Pharmaceuticals USA, Inc. | 1 | $28 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $15 |
Products named: VRAYLAR, REXULTI, COBENFY, TRINTELLIX, FANAPT, Auvelity, AUSTEDO XR, Quviviq.
Industry payments across FL — which companies pay providers there.
